| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
70,932,000 |
| Market
Cap: |
2.78(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$15.81 - $52.44 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company focused on changing the paradigm for the treatment of rare genetic diseases of obesity, which are characterized by early-onset, severe obesity and hyperphagia, a pathological and insatiable hunger. Co. is developing IMCIVREE™ (setmelanotide) as a medicine strategy for a subset of individuals who have severe obesity due to genetic variants that impair the melanocortin-4 receptor pathway, a pathway in the brain that is responsible for regulating hunger, caloric intake and energy expenditure, which consequently affect body weight.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
171,413 |
357,434 |
386,701 |
425,485 |
| Total Sell Value |
$6,861,691 |
$14,691,044 |
$15,456,647 |
$16,295,598 |
| Total People Sold |
7 |
7 |
7 |
8 |
| Total Sell Transactions |
20 |
34 |
41 |
60 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Meeker David P |
President and CEO |
• • – |
2021-03-30 |
4 |
B |
$20.17 |
$201,713 |
D/D |
10,000 |
111,335 |
2.81 |
-33% |
|
| Foley Todd |
Director |
– • – |
2021-03-15 |
4 |
S |
$25.10 |
$25,100,000 |
I/I |
(1,000,000) |
909,258 |
|
24% |
|
| Smith Hunter C |
Chief Financial Officer |
• – – |
2021-01-19 |
4 |
OE |
$6.88 |
$27,520 |
D/D |
4,000 |
33,650 |
|
- |
|
| Desikan Nithya |
Chief Commercial Officer |
• – – |
2020-08-31 |
4 |
AS |
$30.00 |
$750,000 |
D/D |
(25,000) |
43,602 |
|
10% |
|
| Desikan Nithya |
Chief Commercial Officer |
• – – |
2020-08-31 |
4 |
OE |
$6.88 |
$172,000 |
D/D |
25,000 |
68,602 |
|
- |
|
| Desikan Nithya |
Chief Commercial Officer |
• – – |
2020-08-11 |
4 |
OE |
$6.88 |
$99,994 |
D/D |
14,534 |
43,602 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-07-02 |
4 |
S |
$22.04 |
$972,969 |
I/I |
(44,153) |
5,140,408 |
|
-2% |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-07-01 |
4 |
S |
$21.87 |
$558,311 |
I/I |
(25,527) |
5,184,561 |
|
-8% |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-06-30 |
4 |
S |
$22.15 |
$1,371,237 |
I/I |
(61,901) |
5,210,088 |
|
-7% |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-06-29 |
4 |
S |
$22.19 |
$1,154,999 |
I/I |
(52,049) |
5,271,989 |
|
-11% |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-06-26 |
4 |
S |
$23.31 |
$2,020,848 |
I/I |
(86,706) |
5,324,038 |
|
1% |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-06-25 |
4 |
S |
$25.05 |
$289,768 |
I/I |
(11,568) |
5,410,744 |
|
2% |
|
| Foley Todd |
Director |
– • – |
2020-06-25 |
4 |
AS |
$25.41 |
$456,033 |
I/I |
(17,947) |
1,909,558 |
|
-2% |
|
| Foley Todd |
Director |
– • – |
2020-06-24 |
4 |
AS |
$25.34 |
$2,467,812 |
I/I |
(97,388) |
1,927,505 |
|
-8% |
|
| Foley Todd |
Director |
– • – |
2020-06-05 |
4 |
AS |
$20.00 |
$37,920 |
I/I |
(1,896) |
2,024,893 |
|
20% |
|
| Foley Todd |
Director |
– • – |
2020-06-03 |
4 |
AS |
$20.27 |
$369,826 |
I/I |
(18,245) |
2,026,789 |
|
24% |
|
| Foley Todd |
Director |
– • – |
2020-06-02 |
4 |
AS |
$20.23 |
$315,143 |
I/I |
(15,578) |
2,045,034 |
|
25% |
|
| Foley Todd |
Director |
– • – |
2020-06-01 |
4 |
AS |
$20.08 |
$211,543 |
I/I |
(10,535) |
2,060,612 |
|
25% |
|
| Foley Todd |
Director |
– • – |
2020-05-28 |
4 |
AS |
$20.19 |
$386,679 |
I/I |
(19,152) |
2,071,147 |
|
22% |
|
| Foley Todd |
Director |
– • – |
2020-05-27 |
4 |
AS |
$20.13 |
$204,279 |
I/I |
(10,148) |
2,090,299 |
|
16% |
|
| Foley Todd |
Director |
– • – |
2020-05-26 |
4 |
AS |
$20.47 |
$909,298 |
I/I |
(44,421) |
2,100,447 |
|
11% |
|
| Foley Todd |
Director |
– • – |
2020-05-22 |
4 |
AS |
$20.13 |
$541,618 |
I/I |
(26,906) |
2,144,868 |
|
10% |
|
| Foley Todd |
Director |
– • – |
2020-05-21 |
4 |
AS |
$20.25 |
$518,279 |
I/I |
(25,594) |
2,171,774 |
|
6% |
|
| Foley Todd |
Director |
– • – |
2020-05-20 |
4 |
AS |
$20.01 |
$210,645 |
I/I |
(10,527) |
2,197,368 |
|
13% |
|
| Foley Todd |
Director |
– • – |
2020-05-19 |
4 |
AS |
$20.00 |
$52,660 |
I/I |
(2,633) |
2,207,895 |
|
17% |
|
251 Records found
|
|
Page 6 of 11 |
|
|
0.64 (1.66%) 
